Rituxan Hycela
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.rituxanhycela.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Rituxan Hycela
RITUXAN HYCELA is a prescription antibody therapy used for the treatment of Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Chronic Lymphocytic Leukemia (CLL). It is intended for adult patients after they have received at least one full dose of intravenous RITUXAN. The therapy is administered as a subcutaneous injection and can have serious side effects, including risks of infections and severe allergic reactions. RITUXAN HYCELA is not approved for treating any medical conditions other than cancers.Explore more
Popular SearchesRituxan HycelaSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rituxan Hycela your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Rituxan Hycela
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Rituxan Hycela launches new products
Funding: Get notified immidiatlly once Rituxan Hycela has new funding data
Earning: See what the market has to say on Rituxan Hycela recently announced quarterly report
Click to see if Rituxan Hycela had a recent Job posting/layoffs
Check out if Rituxan Hycela is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Rituxan Hycela has recently received funding, and reach out quickly before it becomes old news!
Rituxan Hycela, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Rituxan Hycela
Find 2 more new buyers
Compare Similar Companies to Rituxan Hycela
Compare insights from companies similar to Rituxan Hycela, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Rituxan Hycela is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rituxan Hycela is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rituxan Hycela.
Rituxan Hycela Tech Stack
A closer look at the technologies used by Rituxan Hycela
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rituxan Hycela
Sign Up For FreeTo access detailed company insights
RITUXAN HYCELA is a prescription antibody therapy used for the treatment of Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Chronic Lymphocytic Leukemia (CLL). It is intended for adult patients after they have received at least one full dose of intravenous RITUXAN. The therapy is administered as a subcutaneous injection and can... Read More
